Skip to content

Opko Health OPK Diagnostics — Operating Income

Other segment segments

Pharmaceutical
-$29.68M+14.6%

Similar metrics at other companies

Danaher logo
DHRDiagnostics — Operating Income (Loss)
$674M-6.1%
Labcorp Holdings logo
LHDiagnostics — Operating Income
$458.7M+7.3%
Revvity logo
RVTYDiagnostics — Segment operating income
$76.12M+2.8%
TEC
TECHDiagnostics And Spatial Biology — Operating Income
$10.32M+22.5%
Thermo Fisher Scientific logo
TMOSpecialty Diagnostics — Operating Income (Loss)
$313M+3.0%
Abbott logo
ABTDiagnostic Products — Operating Earnings
$335M-6.7%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's diagnostics — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's diagnostics — operating income?
Opko Health (OPK) reported diagnostics — operating income of -$12.95M in Q1 2026.
How has Opko Health's diagnostics — operating income changed year-over-year?
Opko Health's diagnostics — operating income increased by 45.8% year-over-year, from -$23.92M to -$12.95M.
What is the long-term trend for Opko Health's diagnostics — operating income?
Over 2 years (2022 to 2024), Opko Health's diagnostics — operating income has grown at a -62.7% compound annual growth rate (CAGR), from -$173.66M to -$24.13M.
What does diagnostics — operating income mean?
Measures the profit or loss generated by the diagnostics segment after deducting all operating expenses, including cost of goods sold, SG&A, and R&D. This is the primary metric for assessing the core operational health and profitability of the diagnostics business unit. It excludes interest, taxes, and non-operating items to focus strictly on segment performance.